029-83533393
   info@TaiBSbio.com
 
组织芯片,组织微阵列
 
CA941b贲门癌组织芯片,附病理分级、TNM和临床分期,94例/94点
点 数94例 数94
行 数8列 数12
点直径(mm)1.0厚度(µm)5.0
组织阵列类型石蜡包埋种 属人类
QA/QCH&E and IHC confirmed
ApplicationsRoutine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page.
Notes1.Please keep the slides at 4 ℃ after receiving, and make experiment within 3 months will be better.

2.Bake the slides for 30 minutes at 60℃ before the experiment;

3.Please choose a gentle repair method to avoid tissue detachment.

产品名:CA941b
 
贲门癌组织微阵列芯片,包含80例腺癌,2例鳞状细胞癌,1例腺鳞癌,1例神经内分泌癌,10例癌旁贲门组织,一例一点
 
 
询价  Tel: 029-83533393
 
下载说明书
 
 
Legend:
Eso
-Esophagus
Car
-Cardia
 
AT (*)
 
Malignant (IB)
 
Malignant (IIA)
 
Malignant (IIB)
 
Malignant (III)
TISSUE  ARRAYS CA941b
1
2
3
4
5
6
7
8
9
10
11
12
A
CAR
CAR
CAR
CAR
CAR
CAR
CAR
CAR
CAR
CAR
CAR
CAR
B
CAR
CAR
CAR
CAR
CAR
CAR
CAR
CAR
CAR
CAR
CAR
CAR
C
CAR
CAR
CAR
CAR
CAR
CAR
CAR
CAR
CAR
CAR
CAR
CAR
D
CAR
CAR
CAR
CAR
CAR
CAR
CAR
CAR
CAR
CAR
CAR
CAR
E
CAR
CAR
CAR
CAR
CAR
CAR
CAR
CAR
CAR
CAR
CAR
CAR
F
CAR
CAR
CAR
CAR
CAR
CAR
CAR
CAR
CAR
CAR
CAR
CAR
G
CAR
CAR
CAR
CAR
CAR
CAR
CAR
CAR
CAR
CAR
CAR
CAR
H
ESO
ESO
ESO
CAR
CAR
ESO
ESO
ESO
ESO
ESO
 
PosNoAgeSexOrgan_Anatomic_SitePathology_diagnosisGradeTNMStageTypeTumor SizeisBackUp
A1167MCardiaAdenocarcinoma1T3N0M0IIAMalignant*N
A2263MCardiaAdenocarcinoma2T3N1M0IIBMalignant*N
A3362MCardiaAdenocarcinoma2T3N0M0IIAMalignant6*4.5*2N
A4451MCardiaAdenocarcinoma2T3N0M0IIAMalignant4*3N
A5565MCardiaAdenocarcinoma2T2N1M0IIAMalignant*N
A6670MCardiaAdenocarcinoma2T3N1M0IIBMalignant*N
A7776MCardiaAdenocarcinoma2T3N1M0IIBMalignant*N
A8871MCardiaAdenocarcinoma2T3N1M0IIBMalignant7*3*2.5N
A9962MCardiaAdenocarcinoma2T3N1M0IIBMalignant*N
A101057FCardiaAdenocarcinoma2T3N0M0IIAMalignant*N
A111154MCardiaAdenocarcinoma2T3N2M0IIIMalignant3*2N
A121264MCardiaAdenocarcinoma2T3N1M0IIBMalignant*N
B11352MCardiaAdenocarcinoma2T3N0M0IIAMalignant6*2*1.5N
B21458MCardiaAdenocarcinoma2T3N1M0IIBMalignant*N
B31562MCardiaAdenocarcinoma2T3N1M0IIBMalignant*N
B41659MCardiaAdenocarcinoma2T3N1M0IIBMalignant*N
B51770MCardiaAdenocarcinoma2T3N1M0IIBMalignant*N
B61860MCardiaAdenocarcinoma2T3N1M0IIBMalignant5*3N
B71960FCardiaAdenocarcinoma2T3N1M0IIBMalignant*N
B82063MCardiaAdenocarcinoma2T3N1M0IIBMalignant*N
B92168FCardiaAdenocarcinoma2T3N1M0IIBMalignant*N
B102251MCardiaAdenocarcinoma2T3N0M0IIAMalignant*N
B112369FCardiaAdenocarcinoma with necrosis2T3N1M0IIBMalignant*N
B122450MCardiaAdenocarcinoma2T3N1M0IIBMalignant*N
C12574MCardiaAdenocarcinoma2T3N0M0IIAMalignant*N
C22676MCardiaAdenocarcinoma2T3N1M0IIBMalignant3.5*2.5*1N
C32770MCardiaAdenocarcinoma2T3N1M0IIBMalignant*N
C42858MCardiaAdenocarcinoma2T3N1M0IIBMalignant*N
C52972MCardiaAdenocarcinoma2T3N0M0IIAMalignant4.7*4*1.5N
C63067MCardiaAdenocarcinoma2T3N0M0IIAMalignant6.5*3.5*1.7N
C73175MCardiaAdenocarcinoma (sparse)2T3N0M0IIAMalignant2*2*2N
C83251MCardiaAdenocarcinoma2T3N0M0IIAMalignant4*4N
C93361MCardiaAdenocarcinoma with necrosis2T3N0M0IIAMalignant4*2N
C103471MCardiaAdenocarcinoma2T3N1M0IIBMalignant*N
C113575MCardiaMucinous adenocarcinoma2T3N1M0IIBMalignant*N
C123661MCardiaMucinous adenocarcinoma (sparse)2T3N1M0IIBMalignant8*7N
D13752MCardiaMucinous adenocarcinoma2--3T3N0M0IIAMalignant10*10*1N
D23864MCardiaAdenocarcinoma2--3T3N1M0IIBMalignant*N
D33968MCardiaAdenocarcinoma (sparse)2--3T3N1M0IIBMalignant*N
D44070MCardiaAdenocarcinoma2--3T3N0M0IIAMalignant3*1*2N
D54157MCardiaAdenocarcinoma2--3T3N1M0IIBMalignant*N
D64259MCardiaAdenocarcinoma2--3T3N1M0IIBMalignant*N
D74362MCardiaAdenocarcinoma3T3N1M0IIBMalignant*N
D84470MCardiaAdenocarcinoma3T2N0M0IBMalignant*N
D94559MCardiaAdenocarcinoma (sparse)3T4aN1M0IIIMalignant*N
D104657FCardiaAdenocarcinoma3T2N1M0IIAMalignant*N
D114760FCardiaAdenocarcinoma3T4aN3bM0IIIMalignant*N
D124856MCardiaAdenocarcinoma (sparse)3T4aN1M0IIIMalignant*N
E14973MCardiaAdenocarcinoma3T3N2M0IIIMalignant*N
E25077MCardiaAdenocarcinoma3T3N0M0IIAMalignant2.5*2*1.5N
E35166MCardiaAdenocarcinoma3T3N1M0IIBMalignant*N
E45263MCardiaAdenocarcinoma3T3N1M0IIBMalignant*N
E55349FCardiaAdenocarcinoma3T3N0M0IIAMalignant5*3N
E65466MCardiaAdenocarcinoma3T3N0M0IIAMalignant6*4*3N
E75568MCardiaAdenocarcinoma3T3N0M0IIAMalignant5*3.5N
E85648MCardiaAdenocarcinoma (mucosa )*T3N2M0IIIMalignant5.0N
E95754MCardiaAdenocarcinoma3T3N1M0IIBMalignant8*6.5N
E105857MCardiaAdenocarcinoma3T3N1M0IIBMalignant*N
E115960MCardiaAdenocarcinoma3T3N0M0IIAMalignant3*1.5N
E126051MCardiaAdenocarcinoma (sparse)3T3N3aM0IIIMalignant2*2N
F16175MCardiaAdenocarcinoma3T3N0M0IIAMalignant2*2*1N
F26265FCardiaAdenocarcinoma3T3N0M0IIAMalignant4*4*0.8N
F36368MCardiaAdenocarcinoma3T3N0M0IIAMalignant14*6*4N
F46464MCardiaAdenocarcinoma3T3N0M0IIAMalignant6*4*1.5N
F56560MCardiaAdenocarcinoma (sparse)3T3N3aM0IIIMalignant*N
F66673MCardiaAdenocarcinoma3T3N0M0IIAMalignant8*4N
F76766MCardiaAdenocarcinoma3T3N1M0IIBMalignant*N
F86860FCardiaAdenocarcinoma3T3N0M0IIAMalignant5*2N
F96961MCardiaAdenocarcinoma3T4aN1M0IIIMalignant8*7N
F107051FCardiaAdenocarcinoma3T3N0M0IIAMalignant12*10*4N
F117150FCardiaAdenocarcinoma3T3N2M0IIIMalignant*N
F127265MCardiaAdenocarcinoma with necrosis3T3N1M0IIBMalignant5*4*2.5N
G17352MCardiaAdenocarcinoma3T3N1M0IIBMalignant11*5*3N
G27468MCardiaAdenocarcinoma (sparse)3T3N1M0IIBMalignant*N
G37561MCardiaMucinous adenocarcinoma3T3N0M0IIAMalignant*N
G47663MCardiaMucinous adenocarcinoma3T3N1M0IIBMalignant*N
G57764MCardiaMucinous adenocarcinoma3T3N0M0IIAMalignant9*5N
G67862FCardiaMucinous adenocarcinoma3T4aN0M0IIBMalignant2*1.5N
G77933MCardiaMucinous adenocarcinoma3T3N0M0IIAMalignant5*5N
G88021FCardiaAdenocarcinoma4T4aN0M0IIBMalignant*N
G98162MCardiaSquamous cell carcinoma2T3N3aM0IIIMalignant*N
G108260MCardiaSquamous cell carcinoma2T3N0M0IIAMalignant5*5*4N
G118361FCardiaAdenosquamous carcinoma*T3N0M0IIAMalignant8*4*2N
G128466FCardiaNeuroendocrine carcinoma*T3N0M0IIAMalignant*N
H18562MEsophagusCancer adjacent cardia tissue of No.9***AT*N
H28657FEsophagusCancer adjacent cardia tissue of No.10***AT*N
H38758MEsophagusCancer adjacent cardia tissue of No.14***AT*N
H48863MCardiaCancer adjacent cardia tissue of No.20***AT*N
H58951MCardiaCancer adjacent cardia tissue of No.22***AT*N
H69070MEsophagusCancer adjacent cardia tissue of No.44***AT*N
H79166MEsophagusCancer adjacent cardia tissue of No.51***AT*N
H89254MEsophagusCancer adjacent cardia tissue of No.57***AT8*6.5N
H99366MEsophagusCancer adjacent cardia tissue of No.67***AT*N
H109460FEsophagusCancer adjacent cardia tissue of No.68***AT5*2N
Tissue Marker
 
 
西安泰博斯生物科技有限公司

 
联系我们
地址:陕西西安市灞桥区长乐东路2999号
电话:029-83533393, 17792711553,
电子邮箱:taibsbio@163.com
QQ:3144647811
微信号:13002913390
邮政编码:710075
关于我们
西安泰博斯生物科技有限公司主要经营组织芯片的研发、销售,加工定制和与组织芯片有关的生物技术服务项目。公司目前拥有专业的病理医生和技术研发团队,并且具有庞大的组织标本库。样本库中组织微阵列种类多,病理类型齐全,同时根据客户需求情况进行制作加工新的组织微阵列,尽量满足每一个客户的需求。公司一直秉承着“认真、严谨、负责”的工作态度,致力于为广大客户提供质量好的产品和优质的服务。

更多详情